Healthcare Services

Metabolic Syndrome Industry Expansion Forecast Showing Market Size of $127.95 Billion by 2030 at 7.2% CAGR

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Metabolic Syndrome Market Over The Period 2026–2030?

The metabolic syndrome market size has experienced strong growth in recent years. It is anticipated to expand from $90.34 billion in 2025 to $97.05 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The historical growth can be linked to factors such as the increasing global prevalence of obesity, higher rates of insulin resistance diagnosis, growing awareness of metabolic diseases, the expansion of preventive healthcare programs, and a rising incidence of cardiovascular complications.

The metabolic syndrome market is anticipated to experience robust expansion in the coming years. This market is projected to reach $127.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth stems from factors such as increased adoption of digital therapeutics, greater investment in lifestyle modification platforms, a surge in remote metabolic monitoring usage, the broadening availability of personalized diet and fitness solutions, and the growing integration of AI-based metabolic assessment tools. Key trends expected during this period involve the development of precision-based metabolic disorder management, AI-driven algorithms for early risk detection, cloud-based platforms for health monitoring, IoT-integrated solutions for lifestyle tracking, and the expansion of sustainable metabolic health programs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21218&type=smp

What Drivers Are Expected To Influence The Metabolic Syndrome Market During The Forecast Period?

The metabolic testing market is anticipated to expand due to the rising occurrence of lifestyle diseases. These are health conditions predominantly resulting from unhealthy habits and behaviors, rather than genetic predispositions or infectious agents. Common examples include obesity, cancer, type 2 diabetes, osteoporosis, and various mental health disorders. Factors contributing to their widespread nature include sedentary lifestyles, poor dietary choices, elevated stress, and extensive tobacco and alcohol consumption. Metabolic syndrome significantly worsens lifestyle diseases by establishing a systemic environment conducive to chronic inflammation, compromised metabolic functions, and increased cardiovascular risks. An illustrative example comes from June 2024, where data from the National Health Service England, a UK-based government department, revealed that 3,615,330 individuals were diagnosed with non-diabetic hyperglycemia, or pre-diabetes, in 2023. This figure represents an 18% rise from the 3,065,825 cases documented in 2022. Consequently, the growing incidence of lifestyle diseases is set to propel the metabolic testing market.

How Is The Metabolic Syndrome Market Divided Into Its Major Segments?

The metabolic syndrome market covered in this report is segmented –

1) By Type: Type 1 Metabolic Syndrome, Type 2 Metabolic Syndrome, Type 3 Metabolic Syndrome

2) By Risk Factors: Obesity, Insulin Resistance, High Blood Pressure, High Cholesterol

3) By Treatment: Medication, Lifestyle Changes, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

5) By End User: Hospitals, Homecare, Specialty Centres, Other End Users

Subsegments:

1) By Type 1 Metabolic Syndrome: Insulin Resistance Syndrome, Abdominal Obesity Syndrome, Hyperglycemia Syndrome

2) By Type 2 Metabolic Syndrome: Elevated Blood Pressure Syndrome, Dyslipidemia Syndrome, Low HDL Cholesterol Syndrome

3) By Type 3 Metabolic Syndrome: Atherosclerotic Cardiovascular Disease Syndrome, Non-Alcoholic Fatty Liver Disease Syndrome, Chronic Inflammation Syndrome

How Are Trends Impacting The Metabolic Syndrome Market?

Major companies operating in the metabolic syndrome market are focusing on developing innovative solutions, such as clinically supported probiotic solutions, to enhance the condition’s management, treatment, and prevention. A clinically supported probiotic solution is a probiotic product that has undergone rigorous clinical testing to validate its health benefits and safety for human consumption. For instance, in October 2024, Probi USA, a US-based manufacturer of clinically proven biotics, launched metabolic health. This product combines two probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2). LP299V supports cardiovascular health by improving cholesterol levels, inflammation, and blood vessel function, backed by 230+ publications and eight clinical trials. L. Paracasei 8700:2, with 30+ publications, aids blood pressure regulation, cholesterol management, and weight control.

Who Are The Prominent Organizations Shaping The Metabolic Syndrome Market?

Major companies operating in the metabolic syndrome market are Novo Nordisk A/S, Sanofi S.A., Boehringer Ingelheim GmbH, Eli Lilly and Company, AstraZeneca PLC, Biocon Ltd., Bristol-Myers Squibb Company, Cipla Limited, Herbalife International of America Inc., Abbott Laboratories, Johnson & Johnson Private Limited, Medtronic plc, WW International Inc., Jenny Craig, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche AG, Merck & Co. Inc., Gilead Sciences, GlaxoSmithKline plc, AbbVie Inc., Regeneron Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Esperion Therapeutics Inc.

Read the full metabolic syndrome market report here:

https://www.thebusinessresearchcompany.com/report/metabolic-syndrome-global-market-report

Which Region Is Forecast To Lead The Metabolic Syndrome Market In Terms Of Market Size?

North America was the largest region in the metabolic syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolic syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Metabolic Syndrome Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21218&type=smp

Browse Through More Reports Similar to the Global Metabolic Syndrome Market 2026, By The Business Research Company

Non Alcoholic Steatohepatitis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

Non Alcoholic Steatohepatitis Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

Fatty Liver Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795